Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027
The global Molecular Biology Enzymes & Kits & Reagents market gathered revenue around USD 13.3 Billion in 2020 and market is set to grow USD 31.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 16% during the prediction period 2021 to 2027.
The market Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic disorders. However, limited reimbursements for genetic testing are expected to restrain the growth of this market during the forecast period.
The rising number of genome projects coupled with reducing genetic analysis costs helps advance research in various domains, such as disease treatment, personalized medicine, and microbial genetics. These processes require the use of various molecular biology enzymes and reagents and are thus expected to drive the molecular biology enzymes and kits & reagents market. However, factors such as limited reimbursements for genetic testing are likely to hinder the growth of this market.
The molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 86.1% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Molecular Biology Enzymes & Kits & Reagents market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Molecular Biology Enzymes & Kits & Reagents market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
|Market Size||USD 31.2 Billion by 2027|
|Growth Rate||CAR 16% From 2021 to 2027|
|Forecast Period||2021 to 2027|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Segments Covered||Product, Application, End users and Region|
|Report coverage||Growth Factors, Revenue Status, Competitive Landscape, and Future Trends|
|Companies Mentioned||Thermo Fisher , Merck , Illumina , QIAGEN , New England Biolabs, Promega , Agilent , Roche , Takara Bio , Bio Basic , Jena Bioscience , Molecular Biology Resources , Bio-Rad Laboratories, Inc. .|
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Molecular Biology Enzymes & Kits & Reagents market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America was the largest regional market for molecular biology enzymes and kits & reagents in 2020.
Geographically, the molecular biology enzymes and kits & reagents markets is segmented into North America, Europe, Asia Pacific, RoW. In 2020, North America accounted for the largest share of the molecular biology enzymes and kits & reagents market, followed by Europe & Asia Pacific. The large share of North America in the global market can be attributed to the increasing research funds in translational and clinical research, the growing number of pharmaceutical and biotechnology companies, favourable reimbursement scenario for molecular diagnostics, and the growing investments in research projects in Canada.
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Molecular Biology Enzymes & Kits & Reagents Market are: Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Molecular Biology Enzymes And Kits & Reagents Market, by Product
- Kits & Reagents
- Restriction Endonucleases
- Reverse Transcriptases
- Other Enzymes
Molecular Biology Enzymes And Kits & Reagents, by Application
- Restriction Digestion
- Synthetic Biology
- Other Applications
Molecular Biology Enzymes And Kits & Reagents, by End users
- Academic & Research Institutes
- Pharmaceutical & Biotechnology companies
- Hospitals & Diagnostic Centers
- Other End Users
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa